IMMUNO-ONCOLOGY INSIGHTS

April 2023 Issue

Volume 4 Issue 3

Immuno-oncology Insights Volume 4 Issue 3

Featuring

Issue Spotlight: Modality/platform development trends
Other articles

SPOTLIGHT

Modality/platform development trends
David Dilillo
Guest Editor:
David Dilillo, Senior Director, Immuno-Oncology

Foreword

Spotlight on modality & platform development trends

Spotlight on modality & platform development trends

David Dilillo
2 May 2023
Read

Commentary

Alloplex Biotherapeutic’s SUPLEXA cells represent a new type of autologous adoptive cellular therapy for cancer

Alloplex Biotherapeutic’s SUPLEXA cells represent a new type of autologous adoptive cellular therapy for cancer

Frank Borriello, James A Lederer
25 April 2023
Read

FastFacts

Al pathology in immuno-oncology research

Al pathology in immuno-oncology research

Marija Pezer
2 June 2023
Read

Viewpoint

Advancing best-in-class allogeneic CAR-T therapies

Advancing best-in-class allogeneic CAR-T therapies

Blair Madison
16 April 2023
Read

Interview

Discovering cellular immunotherapy approaches in solid tumors & beyond

Discovering cellular immunotherapy approaches in solid tumors & beyond

Steven M Shamah
22 April 2023
Read
Creating the next generation of antibodies for I–O

Creating the next generation of antibodies for I–O

Rony Dahan
16 April 2023
Read

Journal articles

Innovator Insight

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Sylvia F Boj, Andrea Bisso
9 May 2023
Read

FastFacts

AI-driven image analysis for cancer cell biology

AI-driven image analysis for cancer cell biology

Gillian Lovell
26 March 2023
Read